US 6022861
Ketoheterocyclic inhibitors of factor Xa
expired A61KA61K38/00
Quick answer
US patent 6022861 (Ketoheterocyclic inhibitors of factor Xa) held by COR Therapeutics, Inc. expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- COR Therapeutics, Inc.
- Grant date
- Tue Feb 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K38/00